Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
Développer la qualité dans le champ sanitaire, social et médico-social
Logo
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • Établissements de santé

2 results

  • Language : Français
  • Active substance : rituximab
  • Topics : Virus diseases
Filter
Topic
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Diagnostic techniques and procedures (2)
    • Plus ...
      • Biology (laboratory tests) (2)
    • Transfusions, transplantations (1)
  • Diseases and conditions (2)
  • Plus ...
    • Infectious diseases (2)
    • Plus ...
      • Virus diseases (2)
    • Nervous system diseases (1)
    • Plus ...
      • Central nervous system diseases (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Lymphatic diseases (1)
      • Hematologic cancers (1)
    • Immune system diseases (1)
    • Plus ...
      • Immune system diseases - miscellaneous (1)
Content type
  • Drugs, devices and medical acts (2)
  • Plus ...
    • Health technology assessment (2)
Langue
  • Français (2)
Substance active
  • ganciclovir (1)
  • rituximab (2)
More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 2 results

  • Laboratory examinations to test for Epstein-Barr virus as part of post-transplant lymphoproliferative disorder

    Health technology assessment - Posted on 20/11/2015
    Download document
    Add to my selection

  • Detection of enterovirus genome in cerebrospinal fluid by gene amplification in meningitis patients - INAHTA Brief

    Health technology assessment - Posted on 29/7/2014
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
LnJcBDhA49jHk1b8